Patient Centricity
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.
Search
455 Result(s)
GPP
“Rare diseases are quite common”
Individually, they may be rare. All together they affect millions.
Pulmonary Fibrosis
L`Arte di Respirare in IPF
Expert Prof. Richeldi discusses the link between Idiopathic Pulmonary Fibrosis (IPF) and Leonardo da Vinci, as well as the importance of taking action early.
GPP
Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease
A rare, chronic, systemic autoinflammatory disease that can be life-threatening if left untreated.
Cancer
Brightline-1 trial launch in rare sarcoma
Find out more from Mehdi Lahmar, Clinical Program Leader for Oncology, about our commitment to patients with Dedifferentiated Liposarcoma (DDLPS).
Metabolic Diseases
Partnering in Cardiovascular, Renal and Metabolic Diseases
Our commitment to collaboration with science-driven partners and academia is driven by our ambition to help change the future for people living with cardiovascular, renal and metabolic diseases
Human Health Partnering Interests
Respiratory Diseases
Veterinary Public Health
Zoonotic diseases: 3 things you should know
Diseases that can be transmitted between animals and humans are more common than you may think – and they are on the rise. Find out how this affects you.
October 02, 2023
Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
Fostering Science
Combating complex diseases with data
How Dataland creates disrupting insights for our company
April 11, 2019
Major investment for respiratory diseases completed
Scleroderma
All eyes on patients
EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
Scleroderma
Nurjanah’s story
How a rare disease brought the Bruggeman family together
March 07, 2019
Novel antibody shows potential to transform treatment of rare form of psoriasis
December 15, 2021
U.S. FDA grants priority review for spesolimab in GPP
December 23, 2021
Spesolimab Phase II data
Cancer
A unique take on life with an ultra rare cancer
For Dan, being diagnosed with dedifferentiated liposarcoma (DDLPS), an ultra rare cancer, was life changing, and means that he now makes the most of every single day.
Pulmonary Fibrosis
Addressing the urgent need for new treatments for people living with idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung diseases (ILDs)
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program.
Science Focus
Innovation in CNS Disease Research
Diseases of the central nervous system represent one of the major public health challenges today.
Human Health Partnering Interests
Mental Heath Disorders
Metabolic Diseases
Innovation in Cardio-Renal-Metabolic Diseases
Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.
Corporate Profile
Heart disease and treatments can be similar in humans and animals. How?
Humans and animals are more alike than different. Having a heart disease can affect us similarly, and the way to prevent it can work for all as well. Watch and learn how
GPP
Living with GPP
Ray and Christine share their experiences of living with the rare skin condition, generalized pustular psoriasis (GPP).
Science Stories
Innovation in Medicinal Chemistry: Unlocking Unsolved Diseases
From AI to PROTACs, Darryl McConnell and Jürgen Mack explain how our teams leverage cutting-edge approaches aiming to bring ‘undruggable’ targets within reach.
January 05, 2024